Page last updated: 2024-08-17

isatin and Experimental Neoplasms

isatin has been researched along with Experimental Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Fu, W; Huang, F; Huang, Y; Li, W; Qiu, P; Wang, J; Wei, T; Wu, J; Xu, H; Yao, J; Yu, C; Yun, D; Zhou, X	1
Buneeva, O; Ershov, P; Gnedenko, O; Ivanov, A; Medvedev, A	1
Aboagye, EO; Arstad, E; Glaser, M; Nguyen, QD; Perumal, M; Smith, G	1

Reviews

1 review(s) available for isatin and Experimental Neoplasms

Article	Year
Isatin, an endogenous nonpeptide biofactor: A review of its molecular targets, mechanisms of actions, and their biomedical implications. BioFactors (Oxford, England), 2018, Volume: 44, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; Brain; Cell Line; Gene Expression Regulation; Humans; Isatin; Mice; Monoamine Oxidase; Neoplasms, Experimental; Neuroprotective Agents; Parkinsonian Disorders; Rats; Receptors, Atrial Natriuretic Factor; Species Specificity	2018

Article

Year

Isatin, an endogenous nonpeptide biofactor: A review of its molecular targets, mechanisms of actions, and their biomedical implications.

BioFactors (Oxford, England), 2018, Volume: 44, Issue:2

Topics: Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; Brain; Cell Line; Gene Expression Regulation; Humans; Isatin; Mice; Monoamine Oxidase; Neoplasms, Experimental; Neuroprotective Agents; Parkinsonian Disorders; Rats; Receptors, Atrial Natriuretic Factor; Species Specificity

2018

Other Studies

2 other study(ies) available for isatin and Experimental Neoplasms

Article	Year
Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds. European journal of medicinal chemistry, 2018, Jan-20, Volume: 144 Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Isatin; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Quantitative Structure-Activity Relationship; Tumor Cells, Cultured	2018
Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide. Proceedings of the National Academy of Sciences of the United States of America, 2009, Sep-22, Volume: 106, Issue:38 Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Cisplatin; Cyclophosphamide; Etoposide; Fluorodeoxyglucose F18; Humans; Isatin; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals	2009

Article

Year

Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds.

European journal of medicinal chemistry, 2018, Jan-20, Volume: 144

Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Isatin; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Quantitative Structure-Activity Relationship; Tumor Cells, Cultured

2018

Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide.

Proceedings of the National Academy of Sciences of the United States of America, 2009, Sep-22, Volume: 106, Issue:38

Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Cisplatin; Cyclophosphamide; Etoposide; Fluorodeoxyglucose F18; Humans; Isatin; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals

2009